Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial (vol 36, pg 2508, 2013)

被引：0
作者：
Tomita, K.
机构：
来源：
DIABETES CARE | 2013年 / 36卷 / 12期
关键词：
D O I：
10.2337/dc13-er12b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4172 / 4172
页数：1
相关论文
共 50 条
[21]   Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes (vol 30, pg 1979, 2007) [J].
Goldstein, B. J. ;
Feinglos, M. N. ;
Lunceford, J. K. ;
Johnson, J. ;
Williams-Herman, D. E. .
DIABETES CARE, 2008, 31 (08) :1713-1714
[22]   Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial [J].
Kondo, Yaeko ;
Harada, Norio ;
Hamasaki, Akihiro ;
Kaneko, Shizuka ;
Yasuda, Koichiro ;
Ogawa, Eiichi ;
Harashima, Shin-ichi ;
Yoneda, Hiroko ;
Fujita, Yoshihito ;
Kitano, Norikazu ;
Nakamura, Yoshio ;
Matsuo, Fujio ;
Shinji, Megumi ;
Hinotsu, Shiro ;
Nakayama, Takeo ;
Inagaki, Nobuya .
DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
[23]   Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial [J].
Yaeko Kondo ;
Norio Harada ;
Akihiro Hamasaki ;
Shizuka Kaneko ;
Koichiro Yasuda ;
Eiichi Ogawa ;
Shin-ichi Harashima ;
Hiroko Yoneda ;
Yoshihito Fujita ;
Norikazu Kitano ;
Yoshio Nakamura ;
Fujio Matsuo ;
Megumi Shinji ;
Shiro Hinotsu ;
Takeo Nakayama ;
Nobuya Inagaki .
Diabetology & Metabolic Syndrome, 8
[24]   Glucagon-like peptide-1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52-week, randomized, multicenter trial [J].
Seino, Yutaka ;
Rasmussen, Mads Frederik ;
Nishida, Tomoyuki ;
Kaku, Kohei .
JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (04) :280-286
[25]   Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naive Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial [J].
Ito, Daisuke ;
Inoue, Kazuyuki ;
Saito, Daigo ;
Hamaguchi, Keiko ;
Kaneko, Kimie ;
Sumita, Takashi ;
Inukai, Kouichi ;
Inoue, Ikuo ;
Shimada, Akira .
DIABETES THERAPY, 2021, 12 (12) :3201-3215
[26]   Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial [J].
Hartley, Paul ;
Shentu, Yue ;
Betz-Schiff, Patricia ;
Golm, Gregory T. ;
Sisk, Christine McCrary ;
Engel, Samuel S. ;
Shankar, R. Ravi .
DRUGS & AGING, 2015, 32 (06) :469-476
[27]   Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial [J].
Paul Hartley ;
Yue Shentu ;
Patricia Betz-Schiff ;
Gregory T. Golm ;
Christine McCrary Sisk ;
Samuel S. Engel ;
R. Ravi Shankar .
Drugs & Aging, 2015, 32 :469-476
[28]   Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial [J].
Frias, Juan P. ;
Gonzalez-Galvez, Guillermo ;
Johnsson, Eva ;
Maaske, Jill ;
Testa, Marcia A. ;
Simonson, Donald C. ;
Dronamraju, Nalina ;
Garcia-Sanchez, Ricardo ;
Peters, Anne L. .
DIABETES OBESITY & METABOLISM, 2020, 22 (07) :1083-1093
[29]   Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial [J].
Daisuke Ito ;
Kazuyuki Inoue ;
Daigo Saito ;
Keiko Hamaguchi ;
Kimie Kaneko ;
Takashi Sumita ;
Kouichi Inukai ;
Ikuo Inoue ;
Akira Shimada .
Diabetes Therapy, 2021, 12 :3201-3215
[30]   Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial (vol 11, pg 193, 2013) [J].
Bailey, Clifford J. ;
Gross, Jorge L. ;
Hennicken, Delphine ;
Iqbal, Nayyar ;
Mansfield, Traci A. ;
List, James F. .
BMC MEDICINE, 2013, 11
12345